Ireland’s finance minister spoke of the new optimism and constructiveness surrounding talks between the U.K. and the EU following months of bitter post-Brexit trade disputes.
The Davos elite like to make bold predictions. But they don’t always get them right
The World Economic Forum in Davos, Switzerland, kicks off next week. Here’s a recap of some of the calls made at the high-profile meeting in recent years.
Putin’s military command reshuffle reveals a power struggle at the heart of the Ukraine war
Tension has been mounting in recent months between Russia’s military commanders and Wagner Group leader Yevgeny Prigozhin.
Just one G-7 leader will join the Davos elite this year as regular people battle cost-of-living crisis
While the WEF summit has had low G-7 attendance in the past, one political advisor said leaders would be especially wary amid the cost-of-living crisis.
The U.S. economy and stocks face a difficult year — and could even lag Europe
After a tough 2022, some strategists argue this year could be Europe’s time to shine.
Porsche sees small uptick in global sales despite big drop in Taycan EV
Porsche said a 16% drop in global sales of its electric Taycan were “due to supply chain bottlenecks and limited component availability.”
U.S. announces $3.8 billion security assistance package for Ukraine, European allies
The aid package, the 29th such tranche, brings U.S. commitment to Ukraine’s fight to about $24.9 billion since the beginning of the Biden administration.
U.S. slaps Iran with another round of sanctions over drones used in Russia’s war on Ukraine
The Treasury imposed sanctions on Iran’s Qods Aviation Industries, the country’s top defense manufacturer, for producing unmanned aerial vehicles.
Arrive extra-early at these 15 U.S. airports—up to 3 hours—if you don’t want to miss your flight
Upgraded Points analyzed factors like airport size, number of passengers, and the average TSA wait times to rank major U.S. airports.
BioNTech says it will start cancer vaccine trials in the UK from September
The company aims to test 10,000 personalized mRNA therapies, including cancer vaccines, between September 2023 to the end of the decade.